Search for: "Par Pharmaceutical, Inc."
Results 21 - 40
of 171
Sort by Relevance
|
Sort by Date
3 Sep 2018, 9:16 pm
Par Pharmaceutical, Inc. 1-18-cv-01224; filed August 10, 2018 in the District Court of Delaware • Plaintiff: Horizon Therapeutics, LLC • Defendants: Par Pharmaceuticals, Inc., Par Pharmaceutical Companies, Inc. [read post]
17 Jul 2018, 9:28 am
” Par Pharmaceutical, Inc. v. [read post]
13 Jul 2018, 5:48 pm
Teva Pharmaceuticals USA, Inc., is apertinent intervening case, but did not explain how it isan intervening change in law to the inherency doctrine,especially given that it is an on-sale bar case. 855 F.3d1356 (Fed. [read post]
13 Jul 2018, 1:57 pm
., June 14, 2018, Animal Science Products, Inc. v. [read post]
21 Mar 2018, 1:34 pm
Une de ces unicités a récemment refait surface dans la décision du Federal Circuit dans Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc.: la mise en vente pouvant faire anticiper un dépôt de brevet américain. [read post]
18 Jan 2018, 9:34 am
WARNING LETTERMark BaumImprimis Pharmaceuticals Inc.12264 El Camino Real, Suite 350San Diego, CA 92130Dear Mr. [read post]
14 Jan 2018, 6:34 am
Medtronic, Inc. (2008) 552 U.S. 312, 329; cf. [read post]
13 Jan 2018, 8:00 pm
Wyeth, Inc. [read post]
1 Nov 2017, 4:00 am
TD Canada Trust, 2017 SCC 51 [1] A pharmaceutical company was the victim of a fraudulent cheque scheme implemented by one of its employees. [read post]
24 Oct 2017, 4:15 am
See Par Pharmaceutical, Inc. v. [read post]
29 Sep 2017, 12:26 pm
IPOs and offerings of small pharmaceutical companies are incredibly risky – on par with the risks of penny stocks. [read post]
25 Jul 2017, 8:28 am
Supreme Court in its upcoming term, in the Cyan, Inc. v. [read post]
21 Jul 2017, 8:33 am
" Par Pharm., 773 F.3d at 1195-96. [read post]
17 Jul 2017, 9:41 am
Par Pharm., Inc. v. [read post]
9 May 2017, 9:59 pm
The decision arose out of a patent dispute between Plaintiffs Par Pharmaceutical, Inc., Par Sterile Products, LLC,... [read post]
26 Apr 2017, 7:24 am
.'" Par Pharmaceutical, Inc. et al v. [read post]
8 Nov 2016, 11:53 pm
Actavis acquired Allergan, Inc. in June 2015 and the merged company took Allergan’s name. [read post]
21 Feb 2016, 8:07 pm
Par Pharmaceutical, Inc. 1:15-cv-00886; filed October 2, 2015 in the District Court of Delaware Infringement of U.S. [read post]
26 Jan 2016, 11:23 am
**As one small footnote, Ampyra is not a disease-modifying treatment for MS, in contrast to Copaxone or Tecfidera.link to BNA report: http://www.bna.com/acorda-par-settle-n57982066522/ [read post]
29 Nov 2015, 9:54 pm
• Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical, Inc. [read post]
